Be Ready for New Strategies to Prevent HIV
September 2024
You’ll see two new strategies for HIV prevention...PEP-in-pocket (PIP) and long-acting injectable cabotegravir (Apretude).
PIP is post-exposure prophylaxis (PEP) prescribed in advance...so patients can have meds on hand in case of an unexpected HIV exposure.
Having PEP “in pocket” allows patients to start meds as soon as possible...removing the need to go to the ED within the 72-hour window required to start PEP.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive